CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD 3.630
+0.080 (2.25%)
Jul 31, 2026, 3:32 PM EST
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 376.8 | 370.24 | 366.71 | 370.75 | 381.73 | 262.63 | |
Revenue Growth | 2.96% | 0.96% | -1.09% | -2.88% | 45.35% | 61.92% |
Cost of Revenue | 263.65 | 259.28 | 258.65 | 266.05 | 271.79 | 187.35 |
Gross Profit | 113.14 | 110.96 | 108.06 | 104.7 | 109.93 | 75.28 |
Selling, General & Admin | 100.81 | 99.56 | 101.28 | 97.87 | 102.55 | 70.52 |
Other Operating Expenses | 1.19 | 1.29 | 2.25 | 2.16 | 29.33 | 8.06 |
Total Operating Expenses | 102 | 100.85 | 103.54 | 100.03 | 131.88 | 78.59 |
Operating Income | 11.15 | 10.11 | 4.53 | 4.67 | -21.94 | -3.31 |
Interest Expense | -6.24 | -6.68 | -9.12 | -14.32 | -14.94 | -17.3 |
Other Non-Operating Income (Expense) | - | 0.08 | -0.13 | - | - | - |
Total Non-Operating Income (Expense) | -6.24 | -6.61 | -9.24 | -14.32 | -14.94 | -17.3 |
Pretax Income | 4.85 | 3.35 | -4.47 | -9.6 | -35.9 | -23.74 |
Provision for Income Taxes | -22.02 | -22.77 | 0.03 | -4.19 | -1.54 | -1.01 |
Net Income | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income to Common | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 63 | 63 | 60 | 57 | 48 | 35 |
Shares Outstanding (Diluted) | 65 | 64 | 60 | 57 | 48 | 35 |
Shares Change | 3.43% | 7.03% | 5.06% | 20.20% | 36.88% | 72.00% |
EPS (Basic) | 0.43 | 0.42 | -0.07 | -0.09 | -0.72 | -0.65 |
EPS (Diluted) | 0.42 | 0.41 | -0.07 | -0.09 | -0.72 | -0.65 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 24.7 | 25.23 | 32.4 | 22.65 | 12.29 | 1.92 |
Free Cash Flow Growth | 0.61% | -22.14% | 43.08% | 84.26% | 540.82% | - |
Free Cash Flow Per Share | 0.38 | 0.39 | 0.54 | 0.39 | 0.26 | 0.06 |
Dividends Per Share | 0.080 | 0.040 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 30.03% | 29.97% | 29.47% | 28.24% | 28.80% | 28.66% |
Operating Margin | 2.96% | 2.73% | 1.23% | 1.26% | -5.75% | -1.26% |
Profit Margin | 7.13% | 7.06% | -1.23% | -1.46% | -9.00% | -8.65% |
FCF Margin | 6.56% | 6.81% | 8.84% | 6.11% | 3.22% | 0.73% |
EBITDA | 29.14 | 28.45 | 23.72 | 24.65 | -1.88 | 12.09 |
EBITDA Margin | 7.73% | 7.68% | 6.47% | 6.65% | -0.49% | 4.60% |
EBIT | 11.15 | 10.11 | 4.53 | 4.67 | -21.94 | -3.31 |
EBIT Margin | 2.96% | 2.73% | 1.23% | 1.26% | -5.75% | -1.26% |
Effective Tax Rate | -453.81% | -679.21% | -0.72% | 43.67% | 4.30% | 4.23% |